Compare RANI & CURV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RANI | CURV |
|---|---|---|
| Founded | 2012 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Clothing/Shoe/Accessory Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 126.8M | 124.0M |
| IPO Year | 2021 | 2021 |
| Metric | RANI | CURV |
|---|---|---|
| Price | $1.12 | $1.75 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 6 |
| Target Price | ★ $8.50 | $1.59 |
| AVG Volume (30 Days) | 925.4K | ★ 1.4M |
| Earning Date | 05-12-2026 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 21.05 | ★ 36.36 |
| EPS | N/A | ★ 0.01 |
| Revenue | $1,028,000.00 | ★ $1,103,737,000.00 |
| Revenue This Year | $414.59 | N/A |
| Revenue Next Year | $30.15 | $0.21 |
| P/E Ratio | ★ N/A | $178.00 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.39 | $0.94 |
| 52 Week High | $3.87 | $6.69 |
| Indicator | RANI | CURV |
|---|---|---|
| Relative Strength Index (RSI) | 35.82 | 79.56 |
| Support Level | $1.07 | $1.63 |
| Resistance Level | $1.54 | $1.96 |
| Average True Range (ATR) | 0.07 | 0.14 |
| MACD | -0.03 | 0.06 |
| Stochastic Oscillator | 15.71 | 80.89 |
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.
Torrid Holdings Inc is a direct-to-consumer brand of apparel, intimates, and accessories in North America. The company is focused on fit and offers high-quality products across a broad assortment that includes tops, bottoms, denim, dresses, intimates, activewear, footwear, and accessories. The company has one reportable segment, which includes the operation of the e-commerce platform and stores. The company generates revenue from the sale of apparel, intimates, and accessories through its e-commerce platform and its store locations.